Genetag Technology, Inc.
Atlanta, GA
- UEI
- N78BHV2RJKJ8
- CAGE
- 47UK2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 2421 Kings Arms Dr, Atlanta, GA 30345, USA
- Website
- genetagtech.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Salus Discovery LLC | Monona, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Firebird Biomolecular Sciences LLC | Alachua, FL | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Gate Scientific, Inc. | Milpitas, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Clear Labs Inc. | San Carlos, CA | 621511 Medical Laboratories |
| ABM | Richmond, BC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Genetag Technology, Inc. is a for-profit manufacturer that provides nucleic acid testing products and services to the federal government. According to the company website, Genetag specializes in developing sensitive and reliable qPCR probe systems for molecular diagnostics.
Through federal grants from the National Institutes of Health and the Centers for Disease Control and Prevention, Genetag has provided research and development services focused on infectious disease testing. This includes multiplex assays to detect fungal infections such as valley fever, probes to identify drug resistant hepatitis B and hepatitis C variants, and tests to detect biomarkers of transplant rejection. Additional services cover SNP genotyping linked to dry eye disease, and detection of gene mutations driving cancer recurrence. The federal funding has also supported translational research to convert Genetag's proprietary qPCR technologies into clinical diagnostic tests needing only endpoint analysis.
SBA capabilities narrative
gene probes for single base discrimination
of infectious disease and cancer, including early stage detection
Quick answers
Is Genetag Technology, Inc. registered in SAM.gov?
Yes. Genetag Technology, Inc.'s SAM.gov registration is active through February 2, 2027.
What is Genetag Technology, Inc.'s most recent federal award?
Genetag Technology, Inc.'s most recent federal grant award is Development of a dual-idds probe multiplex test for detecting endemic fungal agents confidential PI: shafer, david… (R21AI169164), from National Institute of Allergy and Infectious Diseases (NIH), on December 6, 2022.
On GovTribe
See Genetag Technology, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors